Position in LEXX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,945
+$2,256 QoQ
Shares Held
14,033
-0.4% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEXX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $570,926,901 across 80 Biotechnology names. LEXX ranks #77 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in LEXX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,945 | 14,033 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,689 | 14,083 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $13,373 | 14,033 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,208 | 14,033 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $23,996 | 14,033 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $29,400 | 14,000 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | — | 14,000 | Shares | Defined | 2024-11-13 | |
| 2021-03-31 | — | 33 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||